These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32600864)

  • 41. Dosage regimen and toxicity risk assessment of linezolid in sepsis patients.
    Dou L; Meng D; Dong Y; Chen L; Han X; Fan D; Dong H
    Int J Infect Dis; 2020 Jul; 96():105-111. PubMed ID: 32251797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linezolid-related adverse effects in clinical practice in children.
    Bayram N; Düzgöl M; Kara A; Özdemir FM; Devrim İ
    Arch Argent Pediatr; 2017 Oct; 115(5):470-475. PubMed ID: 28895694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and risk factors for severe linezolid-associated thrombocytopenia in pediatric patients: An analysis of a public database.
    Yang S; Guo W; Chen M; Hu J; Feng N; Ju M; Qian Y
    Medicine (Baltimore); 2023 Jun; 102(24):e34059. PubMed ID: 37327288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics, toxicity and clinical efficacy of linezolid in Japanese pediatric patients.
    Ogami C; Tsuji Y; To H; Yamamoto Y
    J Infect Chemother; 2019 Dec; 25(12):979-986. PubMed ID: 31208925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal replacement therapy and concurrent fluconazole therapy increase linezolid-related thrombocytopenia among adult patients.
    Hsu YC; Chen SY; Hung YJ; Huang YW
    Sci Rep; 2022 Jun; 12(1):9894. PubMed ID: 35701469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring.
    Gervasoni C; Terzi R; Heidempergher M; Clementi E; Cattaneo D
    Eur J Clin Pharmacol; 2015 Mar; 71(3):383-5. PubMed ID: 25604510
    [No Abstract]   [Full Text] [Related]  

  • 47. Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen.
    Ben Romdhane H; Ben Fredj N; Chaabane A; Ben Aicha S; Chadly Z; Ben Fadhel N; Boughattas N; Aouam K
    Nephrol Ther; 2019 Apr; 15(2):110-114. PubMed ID: 30660586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models.
    Srinivas NR; Syed M
    Drugs R D; 2016 Mar; 16(1):69-79. PubMed ID: 26747454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linezolid-Associated Thrombocytopenia in Children With Renal Impairment.
    Jones SJ; Nichols KR; DeYoung HL; Cox EG; Knoderer CA
    J Pediatric Infect Dis Soc; 2015 Sep; 4(3):272-5. PubMed ID: 26407433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases.
    Choi GW; Lee JY; Chang MJ; Kim YK; Cho Y; Yu YM; Lee E
    Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):228-234. PubMed ID: 30171804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of augmented renal clearance on the lower incidence of linezolid-related hematological toxicity.
    Sánchez-Sanz B; Caro-Teller JM; Gonzalez-Barrios I; Rodríguez-Quesada PP; Hernández-Ramos JA; Ferrari-Piquero JM
    Farm Hosp; 2023; 47(5):190-195. PubMed ID: 37394377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.
    Tessier JM; Puzio T; Young A; Wolfe L; Han J; Duane TM
    Surg Infect (Larchmt); 2015 Aug; 16(4):361-7. PubMed ID: 26207396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination.
    Kaya Kılıç E; Bulut C; Sönmezer MÇ; Ozel Ö; Ataman Hatipoğlu Ç; Tuncer Ertem G; Tülek N; Kınıklı S
    J Infect Dev Ctries; 2019 Oct; 13(10):886-891. PubMed ID: 32084018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Classification Tree Analysis Based On Machine Learning for Predicting Linezolid-Induced Thrombocytopenia.
    Takahashi S; Tsuji Y; Kasai H; Ogami C; Kawasuji H; Yamamoto Y; To H
    J Pharm Sci; 2021 May; 110(5):2295-2300. PubMed ID: 33609520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bicytopenia, especially thrombocytopenia in hemodialysis and non-hemodialysis patients treated with linezolid therapy.
    Kato H; Hamada Y; Hagihara M; Hirai J; Yamagishi Y; Matsuura K; Mikamo H
    J Infect Chemother; 2015 Oct; 21(10):707-12. PubMed ID: 26231318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid.
    Zhang YM; Yu W; Zhou N; Li JZ; Xu LC; Xie ZY; Lu YF; Li LJ
    Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):287-92. PubMed ID: 26063030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia.
    Hanai Y; Matsuo K; Ogawa M; Higashi A; Kimura I; Hirayama S; Kosugi T; Nishizawa K; Yoshio T
    J Infect Chemother; 2016 Aug; 22(8):536-42. PubMed ID: 27321773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombocytopenia with Tedizolid and Linezolid.
    Lee EY; Caffrey AR
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.
    Mori N; Kamimura Y; Kimura Y; Hirose S; Aoki Y; Bito S
    Eur J Clin Pharmacol; 2018 Apr; 74(4):405-411. PubMed ID: 29222713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.